Shiseido has agreed to extend its research alliance with the dermatological laboratory CBRC (Cutaneous Biology Research Center), established by Harvard Medical School Dermatology Research Labs, and Massachusetts General Hospital in Boston, Massachusetts, USA. The new agreement will be effective July 2021 through June 2027.

Established in 1989, CBRC and Shiseido have been collaborating for 30 years on product research and development, specifically research in dermatology including ultraviolet rays and aging, and the development of cosmetic products.